May 16, 2018
Idorsia enrols first patient in study to test lucerastat as treatment for Fabry disease
Idorsia has enrolled the first patient in a Phase 3 registration study to investigate the effect of lucerastat, as an…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
May 10, 2018
Lilly buys ARMO for $1.6 billion
Eli Lilly will buy ARMO BioSciences for $50 per share, or approximately $1.6 billion, the companies said Thursday.
May 8, 2018
Merck, AstraZeneca get EMA’s approval for Lynparza for women with platinum-sensitive ovarian cancer
AstraZeneca and Merck have gotten EMA’s approval of Lynparza tablets for use twice daily, as a maintenance therapy for patients…
May 8, 2018
Probiodrug positioning its pGlu-Abeta antibody in the field of Abeta antibodies
Euronext listed biopharma company Probiodrug AG, a clinical stage developer therapeutics to treat Alzheimer’s disease (AD), has announced that results…
May 7, 2018
Novartis’s Alcon cares project 100 commits to reducing cataract blindness globally
Alcon, a division of Novartis, will give 100 reprocessed Infiniti units to eligible clinics in Asia, Central and South America,…
May 3, 2018
LEH Pharma appoints Sir Henry Riley as Chairman
LEH Pharma, the provider of novel ocular implants for macular disorders, has appointed Sir Henry Riley as Chairman of the…
May 3, 2018
Hikma launches Methotrexate for Inection in USA, which sold for $13 million last year
Hikma Pharmaceuticals’s US subsidiary West-Ward Pharmaceuticals has launched Methotrexate for Injection, USP in a 1g preservative-free presentation and Methotrexate Injection,…
April 26, 2018
Concepta in a deal for myLotus delivery in China
Concepta has signed an agreement with SinoPharm, the largest state-owned pharmaceutical company in China, with annual sales of over £23…
April 25, 2018
Novartis launches FocalView app, providing opportunity for patients to participate in ophthalmology clinical trials from home
Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow…
April 24, 2018
AstraZeneca disappointed in combination of Imfinzi plus tremelimumab
AstraZeneca and MedImmune, its global biologics research and development arm, brought to public high-level results from the Phase III ARCTIC…